measurement of cerebrospinal fluid ( csf ) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline ( approximately 90 % ) occurs in the first 2 years of life .
C0021289
neonates
C0008059
children